206 related articles for article (PubMed ID: 23685504)
21. Late-Onset Post-transplantation Central Nervous System Lymphoproliferative Disorder: Case Report.
Rego Silva J; Macau RA; Oliveira Coelho H; Camelo F; Cruz P; Mateus A; Oliveira A; Oliveira C; Ramos A
Transplant Proc; 2018 Apr; 50(3):857-860. PubMed ID: 29661453
[TBL] [Abstract][Full Text] [Related]
22. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
[TBL] [Abstract][Full Text] [Related]
23. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
Steiner R; Kridel R; Giostra E; McKee T; Achermann R; Mueller N; Manuel O; Dickenmann M; Schuurmans MM; de Leval L; Fehr T; Tinguely M; Binet I; Cogliatti S; Haralamvieva E; Koller M; The Swiss Transplant Cohort Study Stcs ; Dietrich PY
Swiss Med Wkly; 2018; 148():w14596. PubMed ID: 29518251
[TBL] [Abstract][Full Text] [Related]
24. Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.
Valencia-Sanchez C; Steenerson KK; Kelemen K; Orenstein R; Kusne S; Grill MF
J Neurovirol; 2019 Apr; 25(2):280-283. PubMed ID: 30607891
[TBL] [Abstract][Full Text] [Related]
25. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
Ginat DT; Purakal A; Pytel P
J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
[TBL] [Abstract][Full Text] [Related]
27. Late-Onset Central Nervous System Posttransplant Lymphoproliferative Disorder After Lung Transplantation:A Case Report.
Ose N; Minami M; Funaki S; Kanou T; Fukui E; Morii E; Shintani Y
Transplant Proc; 2019 Nov; 51(9):3163-3166. PubMed ID: 31619339
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration.
Porcu P; Eisenbeis CF; Pelletier RP; Davies EA; Baiocchi RA; Roychowdhury S; Vourganti S; Nuovo GJ; Marsh WL; Ferketich AK; Henry ML; Ferguson RM; Caligiuri MA
Blood; 2002 Oct; 100(7):2341-8. PubMed ID: 12239141
[TBL] [Abstract][Full Text] [Related]
29. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
[TBL] [Abstract][Full Text] [Related]
30. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
[TBL] [Abstract][Full Text] [Related]
31. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
Twombley K; Pokala H; Ardura MI; Harker-Murray P; Johnson-Welch SF; Weinberg A; Seikaly M
Pediatr Transplant; 2012 Sep; 16(6):E201-9. PubMed ID: 22646132
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of perforated gastrointestinal posttransplantation lymphoproliferative disorder after heart transplantation.
Osawa H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int Surg; 2015 Feb; 100(2):358-64. PubMed ID: 25692442
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES
Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
Lustberg ME; Pelletier RP; Porcu P; Martin SI; Quinion CD; Geyer SM; Caligiuri MA; Baiocchi RA
Transplantation; 2015 Jun; 99(6):1220-5. PubMed ID: 25427163
[TBL] [Abstract][Full Text] [Related]
35. Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.
Holland E; Altshuler E; Franke AJ
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35977750
[TBL] [Abstract][Full Text] [Related]
36. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.
Drachenberg CB; Abruzzo LV; Klassen DK; Bartlett ST; Johnson LB; Kuo PC; Kumar D; Papadimitriou JC
Hum Pathol; 1998 Jun; 29(6):569-77. PubMed ID: 9635676
[TBL] [Abstract][Full Text] [Related]
38. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
Pickhardt PJ; Siegel MJ; Hayashi RJ; Kelly M
Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
[TBL] [Abstract][Full Text] [Related]
39. Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients.
Tai R; Tirumani SH; Tirumani H; Shinagare AB; Hornick JL; Ramaiya NH
Br J Radiol; 2015 Aug; 88(1052):20140861. PubMed ID: 25989696
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.
Beynet DP; Wee SA; Horwitz SS; Kohler S; Horning S; Hoppe R; Kim YH
Arch Dermatol; 2004 Sep; 140(9):1140-6. PubMed ID: 15381556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]